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Lymphoid eells with an affinity for the epiderm~s 
(epidermotropic lymphocytes) have been proposed to 
play a role in the immune functions of the epidermis. 
However, antigen-presenting Langer hans cells (LC) and 
indeterminate cells are presently the only cells in the 
human epidermis which have been demonstrated to orig-
inate in the bone marrow. Recent studies of murine 
epidermis have identified a population of bone marrow-
derived cells which express Thy-1 antigen and which 
are present in a similar density to, but distinct from, 
LC. We therefore sought to identify the potential human 
analogue of the murine Thy-1 + epidermal cell utilizing 
a battery of antileukocyte reagents in immunohisto-
chemical, flow cytometric, and cell sorting studies. A 
panel of antibodies failed to detect significant numbers 
of human Thy-1 antigen-bearing cells, T cells, B cells, 
monocytes/macrophages (other than LC), and natural 
killer cells in tissue sections, epidermal sheets, and epi-
dermal cell (EC) suspensions. This was the case using 
EC suspensions either unfractionated or fractionated on 
Ficoll-Hypaque to enrich for leukocyte subpopulations. 
· Since the nature of the murine Thy-1 + EC is uncertain, 
it is possible that antibodies directed against well-de-
fined leukocyte subpopulations may not be of value in 
the detection of a potential human analogue. We there-
fore utilized double fluorescence staining with anti-
HLe-1, an antibody which identifies all human leuko-
cytes, and anti-HLA-Dr (Dr), which identifies epidermal 
LC, in order to demonstrate a potential population of 
HLe-1 + Dr- non-LC, bone marrow-derived cells. The 
vast majority of HLe-1 + cells were HLA-Dr+ LC; these 
were present at a density of 608 cells/mm2 in epidermal 
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546 
sheets. A minor population of HLe-1 + cells which did not 
express HLA-Dr (HLe-1 + Dr-) was observed in tissue 
sections, epidermal sheets, and EC suspensions. The 
nondendritic morphology and low density of these HLe-
1 + Dr- EC in epidermal sheets (mean density of 4.2 ± 
1.6 cells/mm2 ) precluded their representing a strict hu-
man analogue of the murine Thy-1 + EC, since murine 
Thy- 1 + EC are dendritic and are present in a density 
similar to that of LC. Purified preparations of the minor 
HLe-1 + Dr- EC population obtained by electronic cell 
sorting or panning and examined ultrastructurally were 
not enriched for any bone marrow-derived cell popula-
tion. Thus, using currently available markers and sort-
ing technology, we have been unable to identify 11 human 
analogue of the murine dendritic Thy-1 + epidermal cell. 
Mammalian epidermis is comprised of a heterogeneo~s pop-
ulation of cells including ectodermally derived keratinocytes 
and melanocytes, mesodermally (bone marrow)-derived Lan-
gerhans cells (LC), and cells of undetermined derivation, the 
Merkel cells [1-3] . In addition, it has been proposed that 
epidermal cells (EC) may provide an inductive microenviron-
ment for distinctive populations of recirculating lymphocytes 
that preferentially infiltrate the epidermis [ 4]. Indeed, EC have 
been shown to secrete a chemoattractant for T lymphocytes 
[5], and it has been reported that lymphocytes constitute 1- 4% 
of the cells in the basal layer of normal human skin [6] . The 
recent identification of a subset of dendritic Thy-1+, Ly-5+ 
bone marrow-derived EC (Thy-1+ EC) distinct from LC in 
murine epidermis [7-10] has therefore excited considerable 
interest since it has been proposed that Thy-1 + EC may be of 
T-celllineage. However, these cells do not express the conven-
tional T-cell markers Lyt-1, -2, or -3 or L3T4 [7,11] and their 
precursors do not appear to exist in large numbArs in the 
thymus [9] . The murine Thy-1 + EC are unlikely to be B cells 
or macrophages, since they lack surface immunoglobulins, class 
II alloantigens, FclgG receptors, C3b receptors, and the mac-
rophage surface markers F4/80 and Mac-1 [11], and are not 
essential for alloantigen presentation by epidermal cells 
(Breathnach and Katz, unpublished data). Although Thy-1 + 
EC express the natural killer cell marker asialo GM 1 [11], it 
has not been demonstrated that fresh preparations of Thy-1 + 
EC possess natural killer activity. The exact nature of these 
cells, therefore, remains to be determined. 
The identification of an additional bone marrow-derived cell 
in murine epidermis, present in similar density to, but distinct 
from, LC could be of considerable significance to our under-
standing of the biology of the human epidermis. We therefore 
sought to demonstrate a human analogue of the murine Thy-
1 + EC. However, after extensive analysis of human epidermis 
with fluorescence microscopy and flow cytometry utilizing a 
battery of antileukocyte reagents, we were unable to detect 
significant numbers of any cells bearing human Thy-1, T-cell, 
B-cell, monocyte/macrophage, or natural killer cell antigens; 
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nor were we able to ident ify or isolate any significant population 
of bone marrow-derived cells (HLe-1 +) that were not LC (Dr+) 
within human epidermis. These findings suggest t hat it is 
unlikely t hat an analogue of the murine dendritic Thy-1 + EC 
exists in human epidermis. 
gated) (Tago); goat antimouse IgG, -y chain specific, affinity purified, 
human serum absorbed (fluorescein - or rhodamine-conjugated) (Kir-
kegaard and Perry, Gaithersburg, Maryland); goat antimouse lgM, I' 
chain specific, affinity purified, human serum absorbed, (fluorescein· 
or rhodamine-conjugated) (Kirkegaard and Perry); F(ab ') 2 goat anti-
rabbit IgG (f1uorescein-conjugated) (Tago); and MOPC 21 IgG purified 
mouse myeloma protein (Litton Bionetics, Kensington, Maryland). 
MATERIALS AND METHODS Immunofluorescence Studies of Tissue Sections 
Antibodies and Their Specificities 
A battery of monoclonal antibodies directed toward human/ murine 
bone marrow-derived ce lls was employed (Table I). Also used were: 
anti-factor VIII (lluoresceinated) (rabbit); huma n factor VIII-related 
antigen (Atlantic Antibodies, Scarborough, Maine); antiasialo GM , 
(unconjugated) (rabbit); glycolipids present on murine natural killer 
ce lls (Wako, Dallas, Texas); goat ant ihuman immunoglobulins, affini ty 
purified (fluoresceinated) (Tago, Burlingame, California); goat anti-
mouse lgG, heavy and light chai n specific, affi ni ty pu rified, human 
serum absorbed (u nconjugated, or fluorescein- or rhodamine-conju-
Four-millimeter punch biopsies of adult forearm, buttock, and leg 
skin were embedded in Tissue-Tek II OCT (Miles Laboratories, Inc., 
Naperville, Illinois) and rapidly frozen. Six micron-thick sections were 
cut either vertically or horizontally and mounted on albuminized slides. 
Sections were incubated with optimal dilutions of the primary antibody 
for 45 min at room temperature, washed 3 times in phosphate-buffered 
saline pH 7.6 (PBS), followed by a 30-min incubation with the second-
step fluorochrome-conjugated antibody. In some instances directly 
conjugated primary monoclonal or polyclonal antibodies were used in 
a one-step procedure. 
Antibody 
Fl5-42-1 
Anti-murine Thy-1 
T200/HLe- 1 
Anti - HLA-Dr/ Leu 10 
Leu 1 
OKT8/ Leu2a 
OKT4/Leu 3a and 3b 
OKT3/Leu 4 
Leu 7 (HNK-1) 
Leu 11 
Leu 5 
Interleukin 2 receptor 
Leu 9 
Leu 15 
Leu 12 
Leu MI 
Leu M 2 (Mac-120) 
Leu M 3 
Leu M4 
Leu M5 
CRII 
OKMl 
OKM5 
Mac-1 
Mono! 
Mono2 
C82 
Leu6/0I<T6 
TABLE I. Monoclonal antibodies directed toward bone marrow-derived ceLLs 
Specificity 
Human Thy-1 antigen (bra in, t hymocyte subsets, splenic periarteriolar lymphocytes, 
postcapillary lymph node venules , fibroblasts) 
Murine Thy-1 antigen (thymocytes, peripheral T cells, bone marrow hematopoietic 
precursors, central and peripheral neu rones, fibroblasts, subsets of natural killer 
ce lls, epidermal ce lls) 
Surface a nt igens expressed on a ll human bone marrow-derived cells/leukocytes 
Class Il a lloant igens on human Langerhans cells, B cells, monocytes, antigen pre-
senting cells, activated T cells. 
Pan T cell a ntigen on human peripheral and thymic T cells 
Cytotoxic/suppressor T cell antigen (human) 
Helper/inducer T cell antigen (human) 
Pan T cell antigen (human) 
Lymphocyte antige n on a ll human large granular lymphocytes 
Human natural killer cell ant.igen which may be FclgG receptor 
Lymphocyte antigen associated with human sheep erythrocyte receptor 
Human receptor for interleukin 2 
Huma n T and null ce ll antigen 
Human leukocyte antigen 
Human B cell antigen 
Human myelomonocytic antigen 
Human monocyte antigen 
Human monocyte a nd macrophage antigen 
Human neutrophilic granu locyte antigen 
Human monocyte and macrophage antigen (95 kD chain shared with LFA-1 and 
MAC-1) 
C3d receptor on human B cells 
Human monocyte a nt igen (C3bi receptor) 
Human monocyte and plate let ant igen 
Human and murine monocyte ant igen (C3bi receptor) 
Human monocyte a ntigen 
Human monocyte antigen 
lgM antivimentin intermediate filamen ts (human and mouse)" 
Human cell surface antigen on cortical thymocytes and Langerhans cells 
Source 
Dr. John Fabre, 
B lond Mcindoe 
Centre for 
Medical Re-
search, Eng-
land 
Becton uickinson 
Sunnyvale, CA 
Hybritech Inc., 
San Diego, CA/ 
Becton Dickin-
son 
Becton Dickinson 
Becton Dickinson 
Ortho Diagnostic 
Systems, Inc. 
Raritan, NJ/ 
Becton Dickin· 
son 
Ortho/Becton 
Dickinson 
Ortho/ Becton 
Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton D ickinson 
Becton Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton Dickinson 
Becton D ickinson 
Becton Dickinson 
Ortho 
Ortho 
Hybritech 
Bethesda Re-
search Labora-
tories (BRL), 
Bethesda, MD 
BRL 
Dermatology 
Branch, NCI, 
Bethesda, MD 
Becton Dickin -
son/Ortho 
a ~onoclonal C82 antibody ra ised to human thymic st roma specific for viment in type intermediate filaments by immunoblotting (KD Cooper, 
H H mtner, S l Katz, unpublished data). 
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Preparation of Epidermal Sheets and Single Cell Suspensions 
Human epiderm is was obtained either from flexor forearms of nor-
mal volunteers using a suction blister device [12] or from keratomed 
sk in of legs removed at surgical amputation. The roofs of suction 
blisters yie lded epidermal sheets free of dermal contaminants and were 
used eit her immediately for immunofluorescence staining or were pro-
cessed to obtain suspensions of disaggregated epidermal ce lls. EC 
suspensions were prepared by t rypsinization as previously described 
[13]. In selected experiments, EC suspensions were subjected to Ficoll-
Hypaque (Litton Bionetics) density gradient cent rifugation in order to 
enrich for bone marrow-derived cells within the epidermis [14]. Epi-
dermal ce lls at t he in te rface (Ficoii-Hypaque EC = FH-EC) and in the 
pellet were t hen harvested and washed 3 times. The viability of EC 
suspensions prior or subsequent to fractionation on Ficoll-Hypaque did 
not differ significantly and ranged between 67- 86%. 
Fluorescence Microscopy of Epidermal S heets and Cell Suspensions 
Epidermal sheets from suction blister roofs were fixed and stained 
with appropriate primary and fluorochrome-labeled second reagent as 
p reviously described [9]. For double fluorescence staining with the 
reciprocal fluorochromes, fluorescein and rhodamine, or fluorescein 
and phycoerythrin, either a one-step or a th ree-step procedure was 
used. In the one-step procedure, a lluorescein-conjugated ant ibody was 
combined with t he relevant phycoerythrin-conjugated antibody in PBS 
containing 1% fetal bovine serum (FBS) and 0.1 % sodium azide and 
incubated wit h t he epidermal sheet for 18 h at 37"C. In t he three-step 
double-staining method, the primary murine lgM or lgG ant ibody was 
followed either by a second-step fluorochrome-conjugated goat anti-
mouse lgM ( ~-t chain-specific) or lgG (-y chain -specific). The third step 
consisted of a mixture of irrelevant monoclonal mouse lgG (MOPC 21) 
(in excess to remove residual anti- IgG specificity of t he second step) 
a·nd an lgG monoclonal antibody directly conjugated with the fluoro-
chrome reciprocal to that used in the second step. Both second and 
t hird steps were incubated in moist chambers at 37"C for 1 h and each 
incubation was followed by 3 washes in PBS. Epidermal sheets were 
then observed en face using a Leitz Orthoplan microscope equipped 
with epitl uorescence, and the density per mm2 of ce lls staining with 
fluorescein alone, rhodamine or phycoerythrin alone, or with both 
fluorochromes was determined by count ing 10 random fields of area 
0.026 mm2 wit h t he use of an ocular grid. 
Single and double staining of epidermal cell suspensions was per-
formed in a similar manner to that described for ep idermal sheets, 
except that each incubation was performed for 45 min at 4"C in the 
conti nuous presence of 0.1 % sodium azide. Dead cells were identified 
by ethidium bromide uptake. In certa in experiments, purified EC 
subsets were cytocentrifuged onto glass slides, fixed in acetone to allow 
visualizat ion of t he cytoskeleton, and double stained with ant iviment in 
and anti -HLA-Dr antibodies. 
Flow Cytometric Analysis 
Flow cytometric analysis was performed on both unfractionated EC 
suspensions which had been passed through a nylon mesh fil te r, and 
on EC suspe nsions fractionated on Ficoii-Hypaque. Staining of these 
preparations was carried out as described above. Flow cytometry was 
performed on a Coul te r model Epics V using an argon lase r with 
excitation wavelength 488 nm. Cells were enumerated relative to log 
in tegrated green fluorescence (LIGF), Jog integrated red fluorescence 
(LlRF), and forward angle in tegrated light scatter (FAILS). Data were 
acquired (25 ,000- 50,000 cells per sample) after setting gates on FAILS 
signals to remove particulate debris. Two-color staining data are pre-
sented as contour plots represent ing t hree-dimensional surfaces in 
which the values of green and red flu orescence intensity per cell define 
the X and Y locations on the two-dimensional plot surface , and the 
number of cells with a given intensity of green and red fluorescence 
defi nes the surface elevation at that particular X and Y in tersection 
[15,16]. 
To identi fy dead EC, propidium iodide (Sigma, St. Louis, Missouri) 
was added at a final concentration of 10 ~-tg/m l to cell suspensions 
during the fin al wash, and t he ce lls were resuspended in PBS containing 
1% FBS and 0.1 % sodium azide. Cell sorting by flow cytometry was 
performed on EC suspensions simul taneously stained wi th flu orescein-
ated HLe-1 and phycoerythrin -conjugated ant i-HLA-Dr in order to 
select for HLe-1 + Dr- cells. 
Enrichment of HLe- /+Dr- EC by Sequential "Pann.in.g" 
EC (1.25 x 109 ) in suspension were "prepared from keratomed skin 
st rips and adjusted to 10 X 10° EC/ml in PBS containing 1% FBS and 
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0.1 % sodium azide. HLe-1 ant ibody was added at a dilution of 1:10 and 
the mixture was incubated for 45 min at 4"C with agitation every 15 
min. Simultaneously, 100 mm2 plastic petri dishes (Falcon #1029, 
Oxnard, California) were coated with a solution of 0.05 M Tris-0.15 M 
NaCL, pH 9.5, containing 1% FBS and 10 ~-t g/rn l affinity-purified, 
human serum-absorbed, goat antimouse IgG at 25"C for 45 min. Both 
cells and plates were washed twice in PBS and fina lly with PBS 
containing 10% FBS and 0.1 % sodium azide. HLe-1-treated EC were 
suspended at 5 x 106/m l, and 20 X 106 EC were added to each coated 
petri dish. Dishes and cells were incubated at 4 "C on a level surface fo r 
40 min, swirled 5 times, and incubated another 40 min. Nonadherent 
(HLe-1- ) cells (keratinocytes and melanocytes) were aspirated from 
t he plates by 5 serial washes in PBS. Adherent (HLe-1 +) EC were 
harvested from the plates by vigorous pipetting [1 3]. 
To further separate the HLe-1 + EC into Dr+ and Dr- subpopulations, 
harvested HLe-1 ... EC were adjusted to 10 X 106 per ml, incubated with 
biotinylated antihuman HLA-Dr for 45 min at 4"C, and washed and 
resuspended in PBS containing 0.1 % bovine serum albumin (BSA) 
(RIA grade, Sigma). These cells were then layered onto avidin DX-
BSA-coated plates, which were prepared in the following manner. 
Plastic petri dishes (Falcon #1029) were coated for 45 min with a 
solution of 50 mM sodium bicarbonate buffer (pH 8.5) conta ining 50 
~-tl/m l avidin DX (Vector Labs, Burlingame, California). The avidin-
coated plates were washed once and incubated for another 20 min in 
sodium bicarbonate buffer containing 0.1% BSA to block nonspeci fic 
binding sites on the plates. The avidin-coated plates were further 
washed 3 times in PBS contain ing 0.1 % BSA. After an 80-min incu-
bation of anti-Dr-sensitized HLe-1 + EC with the coated plates as above, 
nonadherent (HLe-1+ Dr- ) EC were harvested in t he initial aspirate of 
the plates. Adherent (HLe-1+ Dr+) EC were harvested by vigorous 
pi petting after 5 gentle washes of the plates with PBS. 
Ultrastructure of Panned HLe- r , HLe-1"'" Dr ... , and HLe-1"'" Dr- EC 
Cell suspensions were prepared for electron microscopic analysis as 
previously described [13]. 
RESULTS 
Immunofluorescence Staining of Human Skin in Vertical and 
Horizontal Sections of Skin Biopsies 
Sections of skin were stained with a panel of antibodies 
directed against le ukocyte antigens in an attempt to identify 
and localize a potentia l human analogue of the murine Thy- 1+ 
EC in the epidermis. Sections were cut parallel to the skin 
surface (horizontally) in addition to vertically in order to in-
crease t he a rea of epidermis that could be examined. Similar 
findings were obtained on examination of both types of sec-
tions. 
Immunofluorescence staining with both antihuman and an-
timurine Thy-1 antibodies failed to stain cells in human epi-
dermis. Antibodies to the following surface antigens also yielded 
negative results in the epidermis: Leu 1, OKT3, Leu 3a, OKT8, 
OKT10, interleukin 2 receptor, Mac-1, Leu M1, Leu M 3, Leu 
M4, Leu M5, CRII, OKM1 , OKM5, antihuman immunoglobu-
lins, Leu 12, Leu 7, Leu 11, and antiasialo GM1 . In the papillary 
tips and perivascula rly in the dermis, HLe-1, C82, Leu 11 , 
antiasialo GM1 and a ntihuma n Thy-1 regularly bound to oc-
casional cells. Double staining revealed that antihuman Thy-1 
reacted with factor VIII-positive endothelial cells. A substantial 
proport ion of dermal Leu 11 + cells also expressed HLA-Dr, 
suggesting that these cells may represent dermal macrophages 
or antigen-presenting cells. In addition, there was variable 
expression of monocyte markers on scattered dermal cells. 
The human bone marrow-derivation markers T200 and Hle-
1 identified a population of dendritic cells within the epidermis. 
Upon double fluorescent staining with T200 or HLe-1 and anti-
HLA-Dr, it was seen that the vast majority of the cells that 
expressed bone marrow derivation markers simultaneously ex-
pressed HLA-Dr. However, rare nondencl!-itic epidermal cells 
that expressed T200 or HLe-1 but did not express HLA-Dr 
were identified along the basal layer. HLA-Dr+ dendritic EC 
a lso expressed OKT6 and Leu 10 as assessed by double fluores-
cence microscopy. Antivimentin antibody C82 defined two pop-
ulations within the epidermis: suprabasal dendritic cells which 
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were HLA-Dr+ (LC) and basal dendritic cells which did not 
express HLA-Dr (most of which were melanocytes by phase 
microscopy) . Leu M2 produced faint staining of all epidermal 
cells. Positive controls for immunofluorescence staining in-
cluded normal human thymus, human spleen, and murine skin. 
I rnrnunofluorescence Staining of Epidermal Sheets 
Epidermal sheet specimens were also examined because these 
preparations enable vastly greater numbers of epidermal cells 
to be sampled. In general, the patterns of staining with the 
various antibodies were similar to those observed in vertical 
and horizontal sections. Staining with the T200 and HLe-1 
bone marrow-derivation markers revealed a network of dendri-
tic cells. Upon double staining, the vast majority of these cells 
were shown to be LC, since they simultaneously expressed 
HLA-Dr. All HLA-Dr+ cells also bore T6 antigen; the mean 
density of HLA-Dr+, OKT6+ LC was 672 ± 35/mm2 (n = 3 
individuals). HLA-Dr+ dendritic EC (LC) contained vimentin-
type intermediate filaments as assessed by double staining with 
the C82 monoclonal antibody. C82 also identified a separate 
population of Dr- cells which appeared to be in a separate focal 
plane from LC and which probably consisted mainly of melan-
ocytes. In addition, rare HLe-1+ Dr- cells were observed in all 
specimens examined. With a mean of 4.2 ± 1.6/mm2 (n = 7 
individuals) the density of these cells was markedly less than 
that of HLe-1 + Dr+ LC. The HLe-1 + Dr- cell population ap-
peared to be nondendritic and in a separate focal plane from 
LC. Cells that were T6+ Dr- represented an even smaller 
population, with 0.87 cells/mm2 (n = 2 individuals) . Intraepi-
dermal T cells expressing one or more T-cell markers (other 
than T6) in a representative experiment were observed at a 
density of 0.25/mm2 • 
Immunofluorescence Staining of EC Suspensions 
Examination of skin sections and epidermal sheets suggested 
the presence of a small population of HLe-1+ Dr- cells. Al-
though these cells could not be a strict analogue of the murine 
dendritic Thy-1 + EC because of their morphology and low 
density, we nevertheless felt it important to further investigate 
this HLe-1 + Dr- population. To facilitate purification, identi-
fication, and precise quantitation of these cells, we obtained 
EC suspensions using both keratomed leg skin and suction 
blister-derived forearm skin. In different experiments, the total 
number of unfractionated EC harvested from keratomed leg 
skin ranged between 3 x 108 and 1.2 X 109 cells. Recovery of 
viable EC from the interface following Ficoii-Hypaque density 
gradient centrifugation varied between 5-14% of the original 
number of viable EC loaded on the gradient. For suction blister-
derived forearm skin the corresponding figure was 15-28%. 
Antibodies that failed to stain cells of the epidermis in skin 
sections and epidermal sheets also failed to stain EC in suspen-
sion by fluorescence microscopy. In addition, the following 
monoclonal antibodies did not bind to EC in suspensions that 
were unfractionated or partially enriched for bone marrow-
derived cells by Ficoll-Hypaque density gradient centrifugation: 
Leu 5, Leu 9, Leu 15, Leu 8, Mono 1, Mono 2. Rabbit antiasialo 
G M 1 antibody showed only diffuse nonspecific cytoplasmic 
staining of dead cells indistinguishable from that obtained with 
normal rabbit serum. The vast majority of cells that stained 
with leukocyte markers showed the phenotype of LC (HLe-1 + 
T200+ HLA Dr+ OKT6+). In unfractionated EC suspensions 
the LC represented a mean of 1.4 ± 0.3% of all EC (n = 7 
individuals) (Table II). Once again, a small population of HLe-
1 + Dr- cells was observed. Density gradient fractionation of EC 
suspensions over Ficoll-Hypaque resulted in enrichment of 
HLe-1+ cells to 8.5 ± 2.9 of total FH-EC (n = 7 individuals) 
(Table II). The percentage ofHLe-1+ Dr- cells in the interface 
preparation ranged from less than 0.1% to 0. 7% of total cells 
(mean 0.5 ± 0.1 %) (Table II) . Neither HLe-1 +Dr+ nor HLe-1 + 
Dr- cells were selectively lost in the pellets of the Ficoll-
Hypaque gradients; these represented respectively 0.5% and 
<0.05% of the cells in the pellet (Table II). 
EC suspensions were further enriched for HLe-1 + cells by a 
single panning method using goat antimouse lgG-coated plates. 
By double fluorescence microscopy, 95% of viable HLe-1 + EC 
in the panned preparation were HLe-1 + Dr+ and 4.2% were 
HLe-1 + Dr-. Ninety-five percent of cytocentrifuged HLe-1 + 
cells were Dr+ C82+, while 2.8% were Dr- C82+. In a similar 
double-staining experiment, all T200+ cells were C82+. 
Flow Cytometric Analysis of EC suspensions 
To enhance our ability to quantitate minor EC subpopula-
tions, we employed flow cytometry to sample 25,000-50,000 EC 
per analysis. Unfractionated and fractionated EC suspensions 
were incubated with a mixture of fluoresceinated HLe-1 and 
phycoerythrin-conjugated anti-HLA-Dr. Flow cytometric 
analysis of unfractionated EC demonstrated that 1.3% of total 
EC expressed both HLe-1 and HLA-Dr on their surface. The 
vast majority of HLA-Dr+ EC also expressed OKT6, indicating 
these were LC. Only 0.06% of total unfractionated EC were 
HLe-1 +Dr- . Thus, 4.7% of these HLe-1+ cells did not express 
HLA-Dr. 
Using FH-EC enriched for HLe-1 + EC, flow cytometric 
analysis was utilized to generate contour plots which depict 
three parameters: green fluorescence intensity, red fluorescence 
intensity, and number of cells at any given combination of 
intensities. A representative contour plot in which FH-EC were 
stained with fluoresceinated anti-HLe-1 and phycoerythrin-
conjugated anti-Dr (Fig 1) demonstrates that although the vast 
majority of viable HLe-1 + EC also expressed Dr (box b), a small 
but distinct population of viable HLe-1 +Dr- EC were identified 
(box a) . Propidium iodide was used to identify dead cells which 
might nonspecifically stain with fluorochrome-labeled antibod-
ies used (box c). 
Integrated values of specific populations depicted on the 
contour plot in Fig 1 are summarized in Table II along with 
values from 2 additional experiments using Ficoll-Hypaque 
enriched cells. In all 3 experiments, virtually all HLe-1 + EC 
expressed Dr and are thus phenotypically LC. The percentage 
of HLe-1+ Dr- cells was again quite low, even in these prepa-
rations enriched in HLe-1+ cells, and ranged from 0.26-0.68% 
of the total cells. Only 4.9-7.6% of HLe-1 + EC did not express 
HLA-Dr (Table III, last column) . These percentages of HLe-
1 + Dr- cells as a fraction of all HLe-1 + cells are similar to t hose 
observed in unfractionated EC suspensions (4.7%). 
To ~Iucidate the phenotype of a resident populat ion, albeit 
small m number, of bone marrow-derived EC distinct from LC, 
we also performed flow cytometric analysis on FH-EC stained 
with a panel of antibodies directed toward leukocyte subsets. 
Viable total T cells (Leu 1 +) in the epidermis represented a 
mean of only_ 0.16 ± 0.04% of EC (n = 3), despite Ficoli-
Hypaque ennchment for bone marrow-derived leukocytes. 
Fewer than 0.1 % of FH-EC demonstrated reactivity with the 
following monoclonal antibodies: OKT3, OKT8, Leu 2a, Leu 
15, Leu 3a, Leu lla, Leu 7, Mono 1, Mono 2, Leu M3, and 
OKM5. Although Leu-lla appeared to bind a substantial num-
ber of EC, this reactivity was also shown to be the result of 
nonspecific binding to dead cells, as verified by using double 
TABLE II. Phenotype of epidermal cells before and after fractionation 
on Ficoll-Hypaque 
EC 
FH-EC interface 
FH-EC pellet 
1.4 ± 0.3" 
8.5 ± 2.9 
0.5 
0.06 
0.5 ± 0.1 
< 0.05 
HLe- l + 
100 
4.7b 
6.4 
< 10 
• Percent of viable cells using flow cytometric analysis of double-
stained EC (n = 7 individuals) . 
b Percent of total HLe-1+ EC which are HLe-1+ Dr-. 
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FIG l. Contour plot showing flow cytometric analysis of a two-color 
staining experiment on suction blister-derived FH-EC pooled from 5 
individuals. The uertical axis denotes log integrated green !luorescence 
(LJGF) of flu oresceinated anti-HLe-1 a nd t he horizontal axis denotes 
log in tegrated red fluorescence (LIRF) of phycoerythrin-conjugated 
anti-HLA-Dr and propidium iodide. EC showing on ly green fluores-
cence wi t h the fluorescein conjugate a re prese nt in box a; EC showing 
both green and red flu orescence are conta ined within box b; a nd dead 
cells which have taken up large amounts of propidium iodide and which 
f1uoresce intensely red a re contained in box c. After subtracting values 
for nonspecific fluorescence, integrated numbers of EC within the 
boxed a reas were divided by total EC a nalyzed to determine t he 
percentages of tota l ce lls which specillca lly lluoresce. Viable HLe-1 + 
Dr+ LC a re contained in box b and represent 9.3% of tota l FH-EC. 
Viable HLe-1+ or- cells are contained in box a and represent 0.68% of 
total FH-EC. 
TABLE Jll. Flow cytomelric analysis of Ficoll-Hypaque-fractianated 
EC suspensions 
Percentage of total EC with phenotype HLe-1+ Dr-
X 100" 
HLe-1+ Dr+ HLe· l+ Dr+ HLe-1+ Dr- HLe-1•· 
Exp 11' 3.4 3.0 3.0 0.26 7.6 
Exp 21' 13.9 13.3 13.1 0.64 4.9 
Exp 3c 10.3 10.1. 9.3 0.68 6.6 
" Results derived by the formul a represent t he % of a ll HLe-1+ cells 
that do not express HLA-Dr. 
b FH-EC were obtained from keratomed leg skin of 1 individual. 
<FH -EC were obta ined from pooled suction -blister epidermis from 
5 individuals. 
staining with propidjum iodide. As in tissue sections, substan-
tial nonspecific binding of Leu-M2 was found in EC suspen-
sions, with 14.6% of total EC demonstrating surface reactivi ty 
for this antibody. A11alysis of antiasialo GM, antibody binding 
to EC demonstrated nonspecific fluorescence indistinguishable 
from that seen with normal rabbit serum in all individuals. 
Ultrastructure of Sorted Cells Obtained by Panning 
Attempts at enrichment for the HLe-1 + Dr- cell subpopula-
tion by f1uorescence-activated cell sorting resulted in extremely 
low yields. We therefore utilized panning as an alternative 
method to identify the minor HLe-1 + Dr- subpopulation of EC 
seen both by fluorescence microscopy and by flow cytometric 
analysis. Three populations ofEC were obtained by a sequential 
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double-panning method: HLe-1 + Dr+ cells, HLe-1 + Dr- cells, 
and HLe-1- cells. These various populations were examined 
ultrastructurally. Examination of the cell preparation selected 
for HLe-1 + Dr+ EC showed that the panning technique was 
successful in the purification of EC subsets, since this prepa-
ration was markedly enriched (68%) for LC and indeterminate 
cells (cells with ultrastructural features suggestive of LC but 
lacking the typical LC cytoplasmic granules) (Table IV, Fig 
2A). The remaining cells were primarily spinous layer keratin-
ocytes. The HLe-1 + Dr- population, by contrast, contained 4% 
LC/indeterminate cells (Table IV) in addition to spinous layer 
EC. This preparation contained a substantial proportion of 
cells showing the characteristics of so-called dark basal cells 
with electron-dense cytoplasm, with loosely arranged tonofila-
ments, and with or without numerous melanosome packages 
(Fig 2B) [17] as well as elongated granular layer cells. Exami-
nation of a limited quantity of cells obtained by flow cytometric 
sorting revealed a similar distribution of dark basal keratino-
cytes with occasional indeterminate cells. The HLe-1 + Dr-
preparation was not enriched for any type of bone marrow-
derived cell. Specifically, no cells differing in morphology from 
keratinocytes or LC/indeterminate cells were seen. The HLe-
1- FH-EC preparation contained 1% LC, no indeterminate 
cells, and 98% keratinocytes. Large enucleate stratum corneum 
squamous cells were observed in both the HLe-1- and HLe-1 + 
Dr- preparations, but not in the HLe-1 + Dr+ preparation. 
DISCUSSION 
The recent identification of a population of Thy-1 +, asialo 
GM1 + bone marrow-derived cells distinct from LC in murine 
epidermis [7- 11] compelled us to search for its human analogue. 
In this study, using a monoclonal antibody raised against 
human brain Thy-1 a11tigen and an antibody to asialo GM,, we 
were unable to demonstrate either a Thy-1 + or an asialo GM, + 
population in the epidermis. However, the antihuman Thy-1 
antibody used is rest ricted in its specificity to lymphoid cells 
in the thymus, spleen, and lymph nodes and does not react 
with peripheral blood leukocytes [18). Therefore, negative epi-
dermal staining with this antibody alone does not exclude the 
possibJity that a human analogue of the murine Thy-1 + EC 
exists. Accordi11gly, we screened for other potential surface 
markers of a putative human Thy-1 + EC using a battery of 
antibodies directed against a variety of cell surface determi-
nants on bone marrow-derived cells. 
Since the differentiation pathway and immunologic function, 
if any, of the murine dendritic Thy-1 + EC is yet to be deter-
mined, we performed staining with antibodies that recognize 
human T cells, B cells, monocytes/macrophages, and natural 
killer cells, and thereby encompassed phenotypes of all func-
tional possibilities. Epidermal staining with all these antibodies 
was essentially negative in tissue sections, epidermal sheets, 
and in EC suspensions examined by fluorescence microscopy 
and f1ow cytometry. Contrary to the findjngs reported here, LC 
have previously been reported to bind OKT4/Leu 3a antibody 
[19). This discrepancy may be t he result of technical factors , 
since Wood et al utilized acetone fixation and an avidin-biotin 
three-step immunoperoxidase technique. As well, using immu-
nogold staining there seem to be many fewer OKT4 binding 
sites than OKT6 binding sites on LC [20). 
Flow cytometric analysis showed that cells bearing T -cell 
markers represented 0.16 ± 0.09% of EC even in EC suspen-
sions enriched for mononuclear leukocyte subpopulations by 
Fico II · Hypaque density gradient centrifugation. The mean den-
sity ofT cells in the epidermis was 0.25/mm2 (compared to 608 
LC/mm2 ) as assessed by f1uorescence microscopy of epidermal 
sheet preparations. It is possible that the few T cells we 
observed in EC suspensions may have been included as a result 
of dermal contamination of the EC preparations, since scat-
tered dermal T cells were occasionally observed in tissue sec-
tions. These findings suggest that T cells or other leukocytes, 
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TABLE IV. Ultrastructural analysis of FH-EC suspensions after cell sorting by panning using HLe-1 and anti-HLA-Dr antibodies 
Percentage of cells of each type (n = 100 cells) 
Phenotype of 
ce ll population 
HLe-1+ Dr+ 
HLe-1 + Dr-
HLe-1-
Langerhans 
cells" 
60 
1 
1 
n Cells contai ning Birbeck granules. 
Indeterminate 
cells• Dark basal' 
8 2 
3 31 
0 31 
Keratinocytes 
Melanocytes 
Spinousd Granu lare 
30 0 0 
46 18 
67 0 
b Cells ultrastructura lly indistinguishable from LC but lacking Birbeck granules. 
<"Cells with electron-dense cytoplasm , loosely a rranged tonofilaments, with or without numerous melanosome packages. 
d Cells containing prominent compact cytop lasm ic tonofi la ments. 
e Cells containing keratohyaline granules. 
F IG 2. Ultrastructural appearance of panned cells in HLe-1+ Dr+ 
and HLe-1+ Dr- preparations. A , HLe-1+ Dr+ preparation showing 5 
LC (Birbeck granule positive) . Scale bar = 10 ,on . B, HLe- 1+ or-
preparations show ing a "dark" cell with electron-dense cytoplasm, 
loosely arranged tono fil aments, numerous melanosome packages, and 
an indented nucleus. The cytoplasm of t he spinous layer ce ll seen in 
the lower half of the figure is more electron-lucent and contains 
prominent compact tonofil aments. Scale bar = 10 .,m. 
whether resident or "epidermotropic," occur only rarely in 
normal human epiderm is. However, if there were rapid transit 
of such cells through the epidermis, these cells may have 
biologic significance. In inflammatory and neoplastic condi-
tions involving T -cell infiltration, increased levels of T -cell 
trafficking through and interaction with the epidermis may 
occur [4,21- 23]. 
Staining with an t iviment in antibody (C82) in epidermal 
sheets identified two populations of EC in separate focal planes; 
a C82+ Dr+ dendritic population, which presumably consisted 
of LC [24], and a C82+ Dr- population. T he majority of this 
latter population probably represented viment in-containing 
melanocytes [25]. However, since vimentin type intermediate 
filaments are widely distributed among mesenchymally derived 
cells [25] and since murine dendritic Thy-1 + EC contain vi-
mentin intermediate filaments (7], this C82+ Dr- population 
might have contained t he human equivalent of the murine Thy-
1+ EC. 
We further addressed the possible existence of the human 
analogue of the murine Thy-1 + cell by investigating whether 
human epidermis contains a population of HLe-1+ bone mar-
row-derived cells distinct from HLA-Dr+ LC (i.e., HLe-1 + Dr-
eells). The vast majority of HLe-1+ cells in the epidermis also 
expressed Dr, OKT6, and vimentin as assessed by double 
staining of tissue sections, epidermal sheets, and cell suspen-
sions. With t hese markers, LC compri sed approximately 1.3% 
of unfractionated EC, with a density of approx imately 700 
cells/mm~ in epidermal sheet preparations. In addition to the 
overwhelming majority of HLe-1 + Dr+ LC, we regularly ob-
served a minor population of HLe-1 + Dr- cells. In tissue sec-
tions, these appeared nondendritic and basilar in location. In 
epidermal sheets, the mean density of HLe-1 + Dr- cells was 4.2 
± 1.6/mm2 (n = 7). By flow cytometry, these cells represented 
0.06% of unfractionated EC. The percentage of these HLe-1 + 
Dr- EC as a fraction of all HLe-1+ EC consistently ranged 
between 4.2-7.6%, whether from unfract ionated EC, FH-EC, 
or HLe-1 + EC that were purified by panning. 
In order to identify t hese HLe-1 + Dr- EC ultrastructurally, 
we sorted for this population using both flow cytometry and a 
double-panning method. We were able to enrich for HLe-1+ 
Dr+ LC by these methods, demonstrating the usefulness of 
these techniques for sorting EC subpopulations. Examination 
of preparations sorted for HLe-1 + Dr- EC showed that they 
contained 95 % keratinocytes, 1% LC, and 3% indeterminate 
cells (Table IV) . A minor population of T6+ Dr- EC which 
ultrastructurally appear to consist mainly of indeterminate cells 
has been described [26]. Since the HLe-1 + Dr- preparation 
contained a small but definite number of indeterminate cells, 
it is possible that a portion of the HLe-1 + Dr- EC which we 
observed in epidermal sheets, skin sections, and EC suspensions 
may have represented such a subpopulation of indeterminate 
cells. However, many of t he keratinocytes in the HLe-1+ Dr-
preparation obtained both by panning and by flow cytometry 
had the ultrastructural features of so-called dark basal keratin-
ocytes with electron-dense cytoplasm containing loosely ar-
ranged tonofilaments, melanosome packages, and indented nu-
clei [17] (Fig 2B) . It has been suggested that these dark basal 
keratinocytes may represent a population of aging or dying 
cells [17] . Thus, a major portion of the basilar HLe-1 +Dr- EC 
may represent HLe-1 antibody uptake by dark basilar keratin-
ocytes. Taken together, the minor HLe-1+ Dr- EC population 
appears to be heterogenous and is comprised largely of dark 
basilar keratinocytes, as well as a few indeterminate cells and 
few T cells. 
It may be beyond the limitations of current sorting technol-
ogy to purify a very minor population of cells such as HLe-1+ 
Dr- EC, which in this study constituted only 0.06% of all 
unfractionated EC. In any case, the minor population of non-
dendritic HLe-1 + Dr- EC in human epidermis cannot be a strict 
analogue of the murine Thy-1 + EC, since in most strains of 
mice these latter cells are present in a density close to that of 
LC and are dendritic in morphology. In conclusion, although 
this study does not definitively rule out its possible existence, 
using currently available markers for bone marrow-derived 
cells, we have been unable to identify a human analogue of the 
murine dendritic Thy-1 + EC. 
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